Search Results 2231-2240 of 16241 for Epilepsy (Partial Onset)

  1. Telehealth Assessments With Glioma Receiving Oral Chemotherapy - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. ... duration of the study. Participants who do not have financial resources to ...

  2. Neurology - Clinical trials

    ... epilepsy. Analyses of Metabolic Agents Following Brain Radiation. Rochester, Minn. The purpose of this study is to determine the feasibility of serial ...

  3. A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3) - Mayo Clinic

    Participants with AD duration of at least 3 months (participant/parent/guardian may verbally report signs and symptoms of AD with onset at least 3 months prior) ...

  4. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

    ... onset):; p.Ala5Val, p.Ala5Thr, p.Leu39Val, p.Gly42Ser, p.His44Arg, p.Leu85Val, p.Gly94Ala, p.Leu107Val, and p.Val149Gly; OR; SOD1 mutation other than those ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... epilepsy, Brain tumor-associated epilepsy. Show more areas of focus for Kaisorn L. Chaichana, M.D.. Brent A. Chang, M.D.. Otolaryngologist.

  6. Itchy Skin Clinical Trials - Mayo Clinic Research

    Subjects on GSK2330672 will also receive placebo tablets to maintain blinding. The total duration of a subject's participation will be up to 45 days of ...

  7. Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) - Mayo Clinic

    Multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of abatacept to achieve sustained glucocorticoid-free remission in ...

  8. Direct Brain Recording and Stimulation for Memory - Mayo Clinic

    ... epilepsy. 2. Age 18 – 65. Exclusion Criteria: 1. Patients who have cognitive impairments that would limit their ability toparticipate in the memory testing. 2 ...

  9. A Study to Evaluate the Effectiveness, Safety, and Tolerability of NLY01 in Early-stage Parkinson's Disease - Mayo Clinic

    Participation eligibility · Diagnosis of secondary or atypical parkinsonism. · Onset of any parkinsonian motor sign or symptom > 5 years before Screening Visit.

  10. A Study to Investigate Intravenous Tocilizumab in Patients with Moderate-to-Severe COVID-19 Pneumonia (enrolling by invitation only) - Mayo Clinic

    The reliability of sexual abstinence should be evaluated in relation to the duration of the clinical trial and the preferred and usual lifestyle of the patient.